DOT World
Tokyo, Japan· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A Japanese CRO providing flexible, rapid clinical trial support for investigator-initiated studies, corporate drug development, and SaMD/medical device programs.
Broad Life SciencesRare DiseasesDigital Health
Technology Platform
Clinical trial service platform with specialized expertise in investigator-initiated trials and Software as a Medical Device (SaMD) development support, leveraging operational knowledge from 200+ trials.
Opportunities
Growth in Japan's digital health/SaMD sector and increased outsourcing of investigator-initiated trials provide expansion opportunities, particularly as regulatory pathways for software-based medical devices mature.
Risk Factors
High dependency on Japan's domestic clinical research market, competition from larger global CROs, and sensitivity to fluctuations in pharmaceutical and medical device R&D spending.
Competitive Landscape
Competes with other Japanese CROs and global players like IQVIA and Parexel, differentiating through specialized focus on investigator-initiated trials, rare diseases, and SaMD development support for smaller clients.